Improving junior doctor medicine prescribing and patient safety: an intervention using personalised, structured, video-enhanced feedback and deliberate practice.
Aim
This research investigated the effectiveness of an intervention for improving the prescribing and patient safety behaviour of Foundation Year doctors. The intervention consisted of simulated clinical encounters with subsequent personalised, structured, video-enhanced feedback and deliberate practice, undertaken at the start of four-month sub-specialty rotations.
Method
Three prospective, non-randomised control intervention studies were conducted, within two secondary care NHS Trusts in England. The primary outcome measure, error rate per prescriber, was calculated using daily prescribing data. Prescribers were grouped to enable a comparison between experimental and control conditions using regression analysis. A break-even analysis evaluated cost effectiveness. Results
There was no significant difference in error rates of novice prescribers who received the intervention when compared with those of experienced prescribers. Novice prescribers not participating in the intervention had significantly higher error rates(p=0.026, 95% CI Wald 0.093to 1.436; p=0.026, 95% CI 0.031 to 0.397) and patients seen by them experienced significantly higher prescribing error rates (p=0.007, 95% CI 0.025 to 0.157). Conversely, patients seen by the novice prescribers who received the intervention experienced a significantly lower rate of significant errors compared to patients seen by the experienced prescribers (p=0.04, 95% CI -0.068 to -0.001). The break-even analysis demonstrates cost-effectiveness for the intervention.
Conclusion
Simulated clinical encounters using personalised, structured, video-enhanced feedback and deliberate practice improves the prescribing and patient safety behaviour of junior doctors in their Foundation Training. The intervention is cost-effective with potential to reduce avoidable harm.
Funding
This work was supported by:first,Health Education England grant number LEI0085 and Pfizer Limited for an unrestricted medical education grant for the pharmacy team to collect data through an additional member of staff for Study 1; and, second, the Academic Health Science Network and Health Education England for financial support for Studies2 and 3. The funders were not involved in any stage of the research process including the study design, writing of this article and the decision to submit this article for publication. RSP’s time on this research was supported through the NIHR academic clinical lecturership programme
History
Citation
British Journal of Clinical Pharmacology (2020) In PressVersion
- AM (Accepted Manuscript)